Robert Ries

Boehringer Ingelheim (Germany)

Papers

1

Total Citations

66

H-Index

1

About

Robert Ries is a leading figure in respiratory biology and drug discovery, renowned for advancing physiologically relevant in vitro models of the human airway. His research centers on developing miniaturized, high-throughput systems that bridge the gap between traditional cell culture and complex in vivo environments. Ries’s most notable contribution is the creation of a miniaturized 96-Transwell air–liquid interface human small airway epithelial model, published in 2020 and cited 66 times. This breakthrough overcomes critical limitations in respiratory research—namely, the scarcity of primary airway epithelial cells from clinical samples and their limited capacity to divide ex vivo. By engineering a 96-well microplate system that maintains an air–liquid interface, Ries enabled scalable, reproducible assays for studying respiratory diseases, drug permeability, and toxicology. His work has profound implications for accelerating preclinical drug development, reducing animal testing, and personalizing therapies for conditions like asthma, COPD, and cystic fibrosis. Ries’s innovations have positioned him as a key architect of next-generation organ-on-a-chip technologies, earning recognition for transforming how researchers model the human airway. His contributions continue to inspire students and scientists aiming to merge engineering precision with biological fidelity.

Research Focus

Key Achievements

1
H-Index
1
Papers
66
Total Citations
66
Avg Citations/Paper
🏆 Most Cited Paper
Development of a miniaturized 96-Transwell air–liquid interface human small airway epithelial model
66 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Boehringer Ingelheim (Germany)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago